The 10-day RSI Indicator for JRS moved out of overbought territory on November 05, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 instances where the indicator moved out of the overbought zone. In 27 of the 30 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on JRS as a result. In 75 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The Moving Average Convergence Divergence Histogram (MACD) for JRS turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 39 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
JRS moved below its 50-day moving average on November 17, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for JRS moved below the 200-day moving average on October 22, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
JRS broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for JRS crossed bullishly above the 50-day moving average on November 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +1.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where JRS advanced for three days, in 253 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
The Aroon Indicator entered an Uptrend today. In 198 of 253 cases where JRS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
The 10-day RSI Oscillator for PSA moved out of overbought territory on November 12, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 instances where the indicator moved out of the overbought zone. In 22 of the 27 cases the stock moved lower in the days that followed. This puts the odds of a move down at 81%.
The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PSA as a result. In 58 of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.
The Moving Average Convergence Divergence Histogram (MACD) for PSA turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 26 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 58%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PSA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
PSA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
PSA moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PSA crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 47%.
Following a +2.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where PSA advanced for three days, in 181 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Aroon Indicator entered an Uptrend today. In 81 of 233 cases where PSA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 35%.
The Tickeron Price Growth Rating for this company is 22 (best 1 - 100 worst), indicating outstanding price growth. PSA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 27 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 28 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 62 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PSA's P/B Ratio (13.027) is very high in comparison to the industry average of (2.701). P/E Ratio (32.078) is within average values for comparable stocks, (18.006). Projected Growth (PEG Ratio) (3.813) is also within normal values, averaging (11.190). Dividend Yield (0.036) settles around the average of (0.049) among similar stocks. P/S Ratio (10.616) is also within normal values, averaging (8.208).
PSA | ||
|---|---|---|
OUTLOOK RATING 1..100 | 77 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 62 | |
SMR RATING 1..100 | 27 | |
PRICE GROWTH RATING 1..100 | 22 | |
P/E GROWTH RATING 1..100 | 28 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| JRS | PSA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 81% |
| Stochastic ODDS (%) | 2 days ago 83% | 2 days ago 59% |
| Momentum ODDS (%) | 2 days ago 84% | 2 days ago 57% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 58% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 53% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 50% |
| Advances ODDS (%) | 10 days ago 85% | 15 days ago 56% |
| Declines ODDS (%) | 2 days ago 85% | 6 days ago 57% |
| BollingerBands ODDS (%) | 2 days ago 85% | 2 days ago 63% |
| Aroon ODDS (%) | 2 days ago 78% | 2 days ago 35% |
A.I.dvisor tells us that JRS and CUBE have been poorly correlated (+13% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JRS and CUBE's prices will move in lockstep.
| Ticker / NAME | Correlation To JRS | 1D Price Change % | ||
|---|---|---|---|---|
| JRS | 100% | -1.58% | ||
| CUBE - JRS | 13% Poorly correlated | -1.34% | ||
| PSA - JRS | 13% Poorly correlated | -1.06% | ||
| PLD - JRS | 12% Poorly correlated | -1.60% | ||
| SPG - JRS | 11% Poorly correlated | -1.09% | ||
| WELL - JRS | 7% Poorly correlated | +0.45% | ||
More | ||||
A.I.dvisor indicates that over the last year, PSA has been closely correlated with EXR. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if PSA jumps, then EXR could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XSVN | 45.21 | 0.08 | +0.19% |
| BondBloxx Bloomberg Seven Year Target Duration US Treasury ETF (XSVN) | |||
| ARKK | 70.84 | -0.71 | -0.99% |
| ARK Innovation ETF (ARKK) | |||
| DEW | 71.72 | -0.90 | -1.24% |
| WisdomTree Global High Dividend Fund (DEW) | |||
| PUI | 43.38 | -0.70 | -1.58% |
| Invesco Dorsey Wright Utilities Momentum ETF (PUI) | |||
| BPAY | 23.64 | -0.58 | -2.39% |
| iShares FinTech Active ETF (BPAY) | |||